Tartu

Estonia

6 total trials

Filter these 6 trials by phase, condition, sponsor and more.

Open in Search →

A Phase 3 Study to Assess the Safety and Immunogenicity of High-dose Influenza Vaccine in Adults ≥ 60 years of Age Ended recruitment

2024-519743-15-00 5 2025-10-20 Influenza immunisation
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants with Multiple System Atrophy Ended recruitment

2023-504876-12-00 5 2023-10-25 Neurogenic Orthostatic Hypotension
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison with Fingolimod in Children and Adolescents with Relapsing-Remitting Mu … Ended recruitment

2023-506516-40-00 5 2022-02-11 Relapsing-Remitting Multiple Sclerosis
A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy a … Ended

2024-513104-34-00 4 2024-11-25 Major Depressive Disorder
Effect of ALlopurinol in addition to hypothermia for hypoxicischemic Brain Injury on Neurocognitive Outcome Ended

2024-511322-31-00 5 2018-03-26 Brain injury termed “hypoxic-ischemic encephalopathy” (HIE) as a resul
A Study to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and … Ended

2023-504034-22-00 5 2014-12-18 Chronic Lymphocytic Leukemia (CLL)

Showing 1–6 of 6 trials